A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist

Fertil Steril. 2012 Jan;97(1):231-4. doi: 10.1016/j.fertnstert.2011.10.015. Epub 2011 Nov 25.

Abstract

Objective: To describe the management of a patient with a pituitary adenoma secreting follicle-stimulating hormone (FSH) associated with ovarian hyperstimulation who was treated with a gonadotropin-releasing hormone (GnRH) antagonist.

Design: Case report.

Setting: University teaching hospital.

Patient(s): A woman of reproductive age with secondary amenorrhea and ovarian hyperstimulation due to a pituitary adenoma secreting FSH, which persisted after transsphenoidal surgery.

Intervention(s): Clinical treatment with a GnRH antagonist.

Main outcome measure(s): A decrease in serum estradiol levels.

Result(s): During the treatment period, ovarian hyperstimulation decreased as shown by a reduction in estradiol levels and an improvement in the patient's clinical condition and in the ultrasonography parameters.

Conclusion(s): The GnRH antagonist was found to be effective for the short-term treatment of ovarian hyperstimulation secondary to a pituitary adenoma secreting FSH, thus representing a therapeutic option that should be taken into consideration in such cases.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / complications
  • Adenoma / drug therapy*
  • Adenoma / metabolism
  • Adenoma / surgery
  • Adult
  • Female
  • Follicle Stimulating Hormone, Human / metabolism*
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Hormone Antagonists / administration & dosage
  • Humans
  • Ovarian Hyperstimulation Syndrome / drug therapy*
  • Ovarian Hyperstimulation Syndrome / etiology
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism
  • Pituitary Neoplasms / surgery
  • Treatment Outcome

Substances

  • Follicle Stimulating Hormone, Human
  • Hormone Antagonists
  • Gonadotropin-Releasing Hormone
  • ganirelix